title: A modification of the in vivo mixed lymphocyte reaction and rapamycin's effect in this model.
abstract: Rapamycin, a novel macrocyclic immunosuppressive agent, suppresses murine T cell activation in vitro by mechanisms distinct from cyclosporin A (CsA). This study was designed to examine rapamycin and CsA in the host vs graft popliteal lymph node (PLN) model, an in vivo system of T cell-dependent lymphocyte activation. The PLN procedure was modified by using irradiated CTLL-2 cells of C57BL/6 origin, instead of primary mouse splenocytes, as the allogeneic stimulus in C3H/HeN recipient mice. PLN cell proliferation was determined by [3H]-thymidine uptake. We found that the host lymphocyte proliferative response to CTLL-2 cells (H-2b) is greater than the response to mouse Balb/c splenocytes (H-2d). Rapamycin (ip or po) produced a dose-related inhibition of the in vivo mixed lymphocyte reaction. By contrast, the effects of CsA and FK-506 were not dose related within the same dose range (0.006-12 mg/kg). These data indicate that rapamycin is an effective immunosuppressive agent and confirm its ability to affect the allogeneic T cell response in vivo. Furthermore, the pharmacological data suggest that this PLN model utilizing irradiated CTLL-2 cells as an allogeneic stimulus provides a reproducible system to examine mixed lymphocyte reactions in vivo.
authors.affiliation: Wyeth-Ayerst Research, Inflammation/Bone Metabolism Division, Princeton, New Jersey 08543-8000.
authors.forename: L M
authors.initials: LM
authors.lastname: Warner
authors.forename: L M
authors.initials: LM
authors.lastname: Adams
authors.forename: J Y
authors.initials: JY
authors.lastname: Chang
authors.forename: S N
authors.initials: SN
authors.lastname: Sehgal
mesh_terms: D000818:Animals; D002478:Cells, Cultured; D006789:Host vs Graft Reaction / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000494:pharmacology; D007719:Knee Joint; D008198:Lymph Nodes; D007959:Lymphocyte Culture Test, Mixed / Q000379:methods; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008954:Models, Biological; D011090:Polyenes / Q000494:pharmacology*; D020123:Sirolimus; D013154:Spleen / Q000166:cytology; D013602:T-Lymphocytes, Cytotoxic / Q000166:cytology* / Q000187:drug effects
chemical_list: D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011090:Polyenes; D020123:Sirolimus